Mostrar el registro sencillo del ítem

dc.contributor.author
Gomez Cherey, Juan Facundo  
dc.contributor.author
Payalef, Sandra Noemi  
dc.contributor.author
Fleider, Laura  
dc.contributor.author
Reyes, Ana Paula  
dc.contributor.author
Maldonado, Verónica Andrea  
dc.contributor.author
Losada, Mirta Olga  
dc.contributor.author
Chen, Xin  
dc.contributor.author
Cardinal, Lucía Helena  
dc.contributor.author
Wang, Youxiang  
dc.contributor.author
Tatti, Silvio Alejandro  
dc.contributor.author
Perazzi, Beatriz Elizabeth  
dc.date.available
2024-05-02T13:34:31Z  
dc.date.issued
2023-04  
dc.identifier.citation
Gomez Cherey, Juan Facundo; Payalef, Sandra Noemi; Fleider, Laura; Reyes, Ana Paula; Maldonado, Verónica Andrea; et al.; Microbiota unbalance in relation to high-risk human papillomavirus cervical infection; BMJ Publishing Group; International Journal of Gynecological Cancer; 33; 4; 4-2023; 482-488  
dc.identifier.issn
1525-1438  
dc.identifier.uri
http://hdl.handle.net/11336/234389  
dc.description.abstract
Objective To assess vaginal dysfunction using basic vaginal states and the presence of lactobacillary microbiota in patients with HPV infection with no squamous intraepithelial lesions (SIL), low-grade squamous intraepithelial lesion (L-SIL) and high-grade squamous intraepithelial lesion (H-SIL) or squamous cell carcinoma compared to a control group (HPV-negative). To establish the prevalence of bacterial vaginosis, candidiasis and trichomoniasis in the different age groups and to characterize the species of lactobacilli according to type of lesion.Methods Cross-sectional study of patients who underwent clinical examination and collection of vaginal fornixes to study basic vaginal states and culture. Species identification of lactobacilli was performed by mass spectrometry. The Chi-square and Fisher´s test were used. p<0.05 was considered significant. High-risk viral types were determined using a multiplex real time PCR test.Results: A total of 741 patients were analyzed and divided into 3 age groups: Group 1, aged 18 to 24 years (n=138), Group 2, aged 25 to 50 years (n=456) and Group 3, aged over 50 years (n=147). All groups were further divided into HPV-negative (Control), HPV-positive without lesion, L-SIL, H-SIL/squamous cell carcinoma. The prevalence of unbalance basic vaginal states in H-SIL/squamous cell carcinoma was 72.7% (p=0.03) in Group 1, 53.1% (p=0.05) in Group 2, and no cases of unbalance were detected in Group 3. The prevalence of bacterial vaginosis in the H-SIL/squamous cell carcinoma in group 1 was 54.5% and in group 2 was 43.7%. Patients with H-SIL/squamous cell carcinoma had a prevalence of 21.4% of Lactobacillus crispatus, 42.9% of L. jensenii and 14.3% of L. iners.Conclusions: A greater unbalance of vaginal microbiota was observed in patients with squamous intraepithelial lesions (SIL), especially in H-SIL/squamous cell carcinoma. In this group, an increase of L. jensenii and L. iners compared to control was found. L. crispatus had similar prevalence to control group. It is important to characterize the lactobacilli species since the unbalance alters the vaginal microenvironment and acts as a cofactor in the persistence of HPV infection.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
BMJ Publishing Group  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
MICROBIOTA UNBALANCE  
dc.subject
HIGH-RISK HPV  
dc.subject
CERVICAL INFECTION  
dc.subject.classification
Enfermedades Infecciosas  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Microbiota unbalance in relation to high-risk human papillomavirus cervical infection  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2024-05-02T11:22:29Z  
dc.journal.volume
33  
dc.journal.number
4  
dc.journal.pagination
482-488  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Philadelphia  
dc.description.fil
Fil: Gomez Cherey, Juan Facundo. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Payalef, Sandra Noemi. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Fleider, Laura. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Reyes, Ana Paula. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Maldonado, Verónica Andrea. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Losada, Mirta Olga. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Tecnología Farmacéutica; Argentina  
dc.description.fil
Fil: Chen, Xin. No especifíca;  
dc.description.fil
Fil: Cardinal, Lucía Helena. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Wang, Youxiang. No especifíca;  
dc.description.fil
Fil: Tatti, Silvio Alejandro. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Perazzi, Beatriz Elizabeth. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.journal.title
International Journal of Gynecological Cancer  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://ijgc.bmj.com/content/early/2023/01/04/ijgc-2022-003760.citation-tools  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1136/ijgc-2022-003760